Atanasio
Pandiella Alonso
Instituto de Investigaciones Biomédicas Alberto Sols
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (3)
2023
-
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications
Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257
2022
-
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology
Cancers, Vol. 14, Núm. 14
2013
-
ERK5/BMK1 is a novel target of the tumor suppressor VHL: Implication in clear cell renal carcinoma
Neoplasia (United States), Vol. 15, Núm. 6, pp. 649-659